20 completed, 9 unknown, 8 recruiting, 5 withdrawn. 45 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 45 | Completed 20, Unknown 9, Recruiting 8, Withdrawn 5, Not yet recruiting 1, Suspended 1, Terminated 1 |
Follow Hydroxychloroquine: new trials by email Literature Review of Hydroxychloroquine trials Research Report on Hydroxychloroquine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children rituximab, Mycophenolate Mofetil (MMF) Treatment, Cyclophosphamide - Lupus Nephritis | Not applicable | Not yet recruiting | Nanfang Hospital, Southern Medical University | 112 | 2026-06-01 | 2026-06-30 |
| The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea Doxycycline, Hydroxychloroquine, Tofacitinib - Erythematotelangiectatic Rosacea | Not applicable | Recruiting | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 186 | 2026-02-01 | 2026-03-24 |
| Ovarian Hyperstimulation Syndrome Prevention Antagonist protocol for IVF, Modified Agonist protocol for IVF with additive treatments as HCQ - Ovarian Hyper Stimulation Syndrome (OHSS) | Not applicable | Recruiting | Aljazeera Hospital | 300 | 2024-11-17 | 2024-12-18 |
| Effect of HCQ Combined With LT4 on LBR in Euthyroid Women With URPL and TPO-Ab hydroxychloroquine and levothyroxine, Levothyroxine - Recurrent Pregnancy Loss, Euthyroid With Thyroid Antibodies | Not applicable | Recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 796 | 2024-11-15 | 2026-09-30 |
| Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients HCQ, Placebo - Nasopharyngeal Carcinoma | Not applicable | Recruiting | Affiliated Hospital of Nantong University | 30 | 2024-08-01 | 2025-02-18 |
| The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP Hydroxychloroquine Oral Tablet, Eltrombopag - Immune Thrombocytopenia With Positive ANA Antibodies | Not applicable | Recruiting | Yunfeng Cheng | 126 | 2024-07-01 | 2024-06-28 |
| The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP Hydroxychloroquine Oral Tablet, Prednisone tablet - Immune Thrombocytopenia With Positive ANA Antibodies | Not applicable | Recruiting | Yunfeng Cheng | 129 | 2024-04-24 | 2024-06-28 |
| The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP Hydroxychloroquine Oral Tablet, Dexamethasone oral - Immune Thrombocytopenia With Positive ANA Antibodies | Not applicable | Recruiting | Yunfeng Cheng | 129 | 2024-04-24 | 2024-06-28 |
| Hydroxychloroquine in Type 2 Diabetes During Pregnancy Hydroxychloroquine Oral Tablet - Diabetes in Pregnancy, Type 2 Diabetes | Not applicable | Recruiting | National University of Malaysia | 56 | 2024-03-24 | 2025-06-12 |
| Acupuncture Combined With Hydroxychloroquine Acupuncture combined with oral hydroxychloroquine sulfate tablets - Primary Sjögren's Syndrome | Not applicable | Completed | Senyue Zhang | 65 | 2023-01-01 | 2024-05-29 |
| Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients HCQ & AZ vs HCQ+SIR - COVID-19 Patients | Not applicable | Withdrawn | King Hussein Cancer Center | 2022-04-01 | 2022-05-27 | |
| Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19 Enoxaparin, Hydroxychloroquine - COVID-19 Pandemic | Not applicable | Completed | Beni-Suef University | 200 | 2021-06-01 | 2022-04-11 |
| Hydroxychloroquine in Prevention of Preeclampsia Hydroxychloroquine, Folic acid, Low-dose aspirin - Preeclampsia | Not applicable | Completed | Assiut University | 50 | 2021-03-01 | 2023-12-08 |
| Treatment of Pregnancy RA Certolizumab Pegol 200 MG/ML [Cimzia], Hydroxychloroquine, Prednisone - Rheumatoid Arthritis, Pregnancy Related | Not applicable | Unknown | RenJi Hospital | 100 | 2020-12-01 | 2020-10-01 |
| Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 Hydroxychloroquine, Mucodentol, Personal protective equipment - COVID-19 | Not applicable | Withdrawn | Baqiyatallah Medical Sciences University | 2020-08-12 | 2022-08-03 | |
| Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis Hydroxychloroquine, Ivermectin - Coronavirus Infections | Not applicable | Unknown | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | 400 | 2020-07-20 | 2020-10-06 |
| Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers Hydroxychloroquine - Coronavirus Disease 2019 (COVID-19), Post-Exposure Prophylaxis | Not applicable | Unknown | Rambam Health Care Campus | 582 | 2020-07-01 | 2020-07-23 |
| Ivermectin In Treatment of COVID 19 Patients Ivermectin - Covid19 | Not applicable | Unknown | Ministry of Health and Population, Egypt | 100 | 2020-06-09 | 2020-06-11 |
| Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic Ivermectin, Hydroxychloroquine, personal protective Measures - Covid19 | Not applicable | Completed | Benha University | 600 | 2020-06-08 | 2020-12-16 |
| Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 Low-dose radiotherapy, Hydroxychloroquine Sulfate, Ritonavir/lopinavir - Pneumonia, Viral | Not applicable | Unknown | Grupo de Investigación Clínica en Oncología Radioterapia | 106 | 2020-06-05 | 2021-07-30 |
Showing 20 of 45. Sign in to see all of them.
COVID-19 (15) · Coronavirus Infections (4) · Arthritis, Rheumatoid (3) · Diabetes Mellitus, Type 2 (2) · Hashimoto Disease (2) · Pneumonia, Viral (2) · Antiphospholipid Syndrome (1) · Behcet Syndrome (1) · Chronic Disease (1) · Chronic Urticaria (1) · Cytokine Release Syndrome (1) · Diabetes Mellitus (1) · Diabetes, Gestational (1) · Emergencies (1) · Lung Diseases, Interstitial (1)
Assiut University (3) · Yunfeng Cheng (3) · Baqiyatallah Medical Sciences University (2) · King Hussein Cancer Center (2) · National Taiwan University Hospital (2) · RenJi Hospital (2) · Affiliated Hospital of Nantong University (1) · Aljazeera Hospital (1) · Alkarkh Health Directorate-Baghdad (1) · Benha University (1) · Beni-Suef University (1) · Children's Hospital of Fudan University (1) · Fundacion GenesisCare (1) · Grupo de Investigación Clínica en Oncología Radioterapia (1) · Hamad Medical Corporation (1)
China (11) · Egypt (7) · Hong Kong (3) · Macau (3) · Taiwan (3) · Indonesia (2) · Iran (2) · Jordan (2) · Kenya (2) · Spain (2) · United States (2) · Benin (1) · Brazil (1) · Canada (1) · Côte d’Ivoire (1)
Yunfeng Cheng (3) · Ahmad Alaskar (1) · Ahmed G Elgazzar, M.D. (1) · Ahmed S Abdulamir, PhD (1) · Andrea Natale, MD (1) · Angel Montero, MD, PhD (1) · Bo You, Doctor (1) · Clay F. Semenkovich, M.D. (1) · James R. O'Dell (1) · John Fahrenholz, MD (1) · Keith R. Fowke, PhD (1) · Liangjing Lu (1) · Liangjing Lu, doctor (1)
PMID 24254965, PMID 28416506, PMID 35288899, PMID 10648016, PMID 12090565, PMID 16368644, PMID 16716321, PMID 17075810, PMID 17487675, PMID 1750226, PMID 1757934, PMID 18667193, PMID 19390908, PMID 20447951, PMID 20528832, PMID 22635227, PMID 22907572, PMID 23755969, PMID 24348219, PMID 24818590, PMID 24917564, PMID 25280034, PMID 25305214, PMID 26384980, PMID 26429521, PMID 26617214, PMID 26712327, PMID 27756248, PMID 27994091, PMID 28388820, PMID 28893304, PMID 29030361, PMID 29150641, PMID 29623679, PMID 31060383, PMID 31933547, PMID 31986261, PMID 31986264, PMID 32061333, PMID 32065057, PMID 32091533, PMID 32113824, PMID 32140081, PMID 32171740, PMID 32173110, PMID 32181795, PMID 32205204, PMID 32342871, PMID 32373721, PMID 32613089
2019 (1)